Summary
Alzheimer's Screening and Prevention Act or the ASAP Act This bill provides for Medicare coverage of blood tests to screen for the early stages of Alzheimer’s disease or related dementias. Specifically, the bill provides for coverage of genomic sequencing blood or blood product tests, or other equivalent tests, that are approved by the Food and Drug Administration.
Summary written by the Congressional Research Service, Library of Congress. Heard is not affiliated with it. Written at: Introduced in Senate, 11/20/2025.
Bill text
Read the full text of the Introduced in Senate version (11/20/2025), exactly as published — 2,261 characters.
Read the full text- Introduced in Senate11/20/2025On HeardOfficial document (HTML)
Roll-call record
How representatives voted
0 yea·0 nay
No roll-call votes recorded for this bill yet.